299 related articles for article (PubMed ID: 15563548)
41. Dissociation of body growth and adipose deposition effects of growth hormone in oMt1a-oGH transgenic mice.
Oberbauer AM; Stiglich C; Murray JD; Keen CL; Fong DL; Smith LB; Cushwa S
Growth Dev Aging; 2004; 68(1):33-45. PubMed ID: 15307663
[TBL] [Abstract][Full Text] [Related]
42. LEPROT and LEPROTL1 cooperatively decrease hepatic growth hormone action in mice.
Touvier T; Conte-Auriol F; Briand O; Cudejko C; Paumelle R; Caron S; Baugé E; Rouillé Y; Salles JP; Staels B; Bailleul B
J Clin Invest; 2009 Dec; 119(12):3830-8. PubMed ID: 19907080
[TBL] [Abstract][Full Text] [Related]
43. Differential expression of suppressors of cytokine signalling genes in response to nutrition and growth hormone in the septic rat.
Johnson TS; O'Leary M; Justice SK; Maamra M; Zarkesh-Esfahani SH; Furlanetto R; Preedy VR; Hinds CJ; El Nahas AM; Ross RJ
J Endocrinol; 2001 May; 169(2):409-15. PubMed ID: 11312157
[TBL] [Abstract][Full Text] [Related]
44. The novel roles of liver for compensation of insulin resistance in human growth hormone transgenic rats.
Cho Y; Ariga M; Uchijima Y; Kimura K; Rho JY; Furuhata Y; Hakuno F; Yamanouchi K; Nishihara M; Takahashi S
Endocrinology; 2006 Nov; 147(11):5374-84. PubMed ID: 16916956
[TBL] [Abstract][Full Text] [Related]
45. Discrimination between signaling pathways in regulation of specific gene expression by insulin and growth hormone in hepatocytes.
Ribaux P; Gjinovci A; Sadowski HB; Iynedjian PB
Endocrinology; 2002 Oct; 143(10):3766-72. PubMed ID: 12239086
[TBL] [Abstract][Full Text] [Related]
46. Muscle mechano growth factor is preferentially induced by growth hormone in growth hormone-deficient lit/lit mice.
Iida K; Itoh E; Kim DS; del Rincon JP; Coschigano KT; Kopchick JJ; Thorner MO
J Physiol; 2004 Oct; 560(Pt 2):341-9. PubMed ID: 15308683
[TBL] [Abstract][Full Text] [Related]
47. Decreases in growth hormone receptor signal transduction contribute to the decline in insulin-like growth factor I gene expression with age.
Xu X; Bennett SA; Ingram RL; Sonntag WE
Endocrinology; 1995 Oct; 136(10):4551-7. PubMed ID: 7664676
[TBL] [Abstract][Full Text] [Related]
48. Suppressor of cytokine signaling 2 regulates neuronal differentiation by inhibiting growth hormone signaling.
Turnley AM; Faux CH; Rietze RL; Coonan JR; Bartlett PF
Nat Neurosci; 2002 Nov; 5(11):1155-62. PubMed ID: 12368809
[TBL] [Abstract][Full Text] [Related]
49. Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA binding.
Chen Y; Sun D; Krishnamurthy VM; Rabkin R
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1856-62. PubMed ID: 17327369
[TBL] [Abstract][Full Text] [Related]
50. Tissue-specific regulation of growth hormone (GH) receptor and insulin-like growth factor-I gene expression in the pituitary and liver of GH-deficient (lit/lit) mice and transgenic mice that overexpress bovine GH (bGH) or a bGH antagonist.
Iida K; Del Rincon JP; Kim DS; Itoh E; Nass R; Coschigano KT; Kopchick JJ; Thorner MO
Endocrinology; 2004 Apr; 145(4):1564-70. PubMed ID: 14726438
[TBL] [Abstract][Full Text] [Related]
51. Rapid increase in fibroblast growth factor 21 in protein malnutrition and its impact on growth and lipid metabolism.
Ozaki Y; Saito K; Nakazawa K; Konishi M; Itoh N; Hakuno F; Takahashi S; Kato H; Takenaka A
Br J Nutr; 2015 Nov; 114(9):1410-8. PubMed ID: 26330054
[TBL] [Abstract][Full Text] [Related]
52. A potential link between muscle peroxisome proliferator- activated receptor-alpha signaling and obesity-related diabetes.
Finck BN; Bernal-Mizrachi C; Han DH; Coleman T; Sambandam N; LaRiviere LL; Holloszy JO; Semenkovich CF; Kelly DP
Cell Metab; 2005 Feb; 1(2):133-44. PubMed ID: 16054054
[TBL] [Abstract][Full Text] [Related]
53. Regulation of energy metabolism by long-chain fatty acids.
Nakamura MT; Yudell BE; Loor JJ
Prog Lipid Res; 2014 Jan; 53():124-44. PubMed ID: 24362249
[TBL] [Abstract][Full Text] [Related]
54. Skeletal muscle-specific deletion of lipoprotein lipase enhances insulin signaling in skeletal muscle but causes insulin resistance in liver and other tissues.
Wang H; Knaub LA; Jensen DR; Young Jung D; Hong EG; Ko HJ; Coates AM; Goldberg IJ; de la Houssaye BA; Janssen RC; McCurdy CE; Rahman SM; Soo Choi C; Shulman GI; Kim JK; Friedman JE; Eckel RH
Diabetes; 2009 Jan; 58(1):116-24. PubMed ID: 18952837
[TBL] [Abstract][Full Text] [Related]
55. STAT5b is required for GH-induced liver IGF-I gene expression.
Davey HW; Xie T; McLachlan MJ; Wilkins RJ; Waxman DJ; Grattan DR
Endocrinology; 2001 Sep; 142(9):3836-41. PubMed ID: 11517160
[TBL] [Abstract][Full Text] [Related]
56. Time course of the GH/IGF axis response to fasting and increased ration in chinook salmon (Oncorhynchus tshawytscha).
Pierce AL; Shimizu M; Beckman BR; Baker DM; Dickhoff WW
Gen Comp Endocrinol; 2005 Feb; 140(3):192-202. PubMed ID: 15639147
[TBL] [Abstract][Full Text] [Related]
57. GH/STAT5 signaling during the growth period in livers of mice overexpressing GH.
Martinez CS; Piazza VG; Díaz ME; Boparai RK; Arum O; Ramírez MC; González L; Becú-Villalobos D; Bartke A; Turyn D; Miquet JG; Sotelo AI
J Mol Endocrinol; 2015 Apr; 54(2):171-84. PubMed ID: 25691498
[TBL] [Abstract][Full Text] [Related]
58. Loss of signal transducer and activator of transcription 5 leads to hepatosteatosis and impaired liver regeneration.
Cui Y; Hosui A; Sun R; Shen K; Gavrilova O; Chen W; Cam MC; Gao B; Robinson GW; Hennighausen L
Hepatology; 2007 Aug; 46(2):504-13. PubMed ID: 17640041
[TBL] [Abstract][Full Text] [Related]
59. Intact insulin and insulin-like growth factor-I receptor signaling is required for growth hormone effects on skeletal muscle growth and function in vivo.
Kim H; Barton E; Muja N; Yakar S; Pennisi P; Leroith D
Endocrinology; 2005 Apr; 146(4):1772-9. PubMed ID: 15618350
[TBL] [Abstract][Full Text] [Related]
60. Estrogen up-regulates hepatic expression of suppressors of cytokine signaling-2 and -3 in vivo and in vitro.
Leong GM; Moverare S; Brce J; Doyle N; Sjögren K; Dahlman-Wright K; Gustafsson JA; Ho KK; Ohlsson C; Leung KC
Endocrinology; 2004 Dec; 145(12):5525-31. PubMed ID: 15319356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
